Viewing nowCombinationCorpozione 5/80 mg
Amlodipine Besylate 6.94mg · Valsartan 80mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.

MFDS item code 201702128 · Approved 2017.04.26 · Insurance code 054800030
Treatment of essential hypertension not controlled with monotherapy
Essential hypertension is a condition that can burden the cardiovascular system. This medication is used as an additional treatment option when blood pressure control with amlodipine or valsartan alone is insufficient. Both drugs help effectively lower blood pressure, contributing to the maintenance of heart and vascular health. It contributes to more stable management of the patient's blood pressure, thereby reducing the risk of complications. This medication is used in the treatment of essential hypertension.
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using an individual component as described below, switching directly to this medication may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. For patients taking valsartan and amlodipine concomitantly, they may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medication should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to this medication, pregnant or breastfeeding women, patients with severe kidney or liver disease, and patients with certain heart diseases should not take this medication. Patients with sodium or fluid deficiency should replenish their condition before taking this medication, and during treatment, blood pressure and symptoms should be carefully monitored. Patients with high potassium levels should frequently check their potassium levels when taking this medication with potassium supplements or potassium-sparing diuretics. Patients with renal artery stenosis or those who have recently received a kidney transplant require special caution due to the risk of worsened kidney function with this medication. If symptoms of angioedema, such as swelling of the face, lips, or tongue, occur during use, the medication should be discontinued immediately and not re-administered. Patients with heart failure or after myocardial infarction should monitor kidney function changes while taking this medication, and some heart disease patients need to exercise caution. When combined with other antihypertensive agents or certain medications, there may be an increased risk of side effects like hypotension, kidney dysfunction, and hyperkalemia, so regular blood pressure and blood tests are necessary. Dizziness or fatigue may occur when driving or operating machinery, so caution is advised. In case of overdose, symptoms such as hypotension, dizziness, arrhythmia, and, in severe cases, shock may occur, requiring immediate contact with a medical institution. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been adequately established. In the elderly, it can be taken at the same dose as the general adult population, but caution is required depending on physical condition. Women who are pregnant, planning to become pregnant, or breastfeeding must consult a physician before taking this medication and should avoid it during pregnancy.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbance, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, weakness, frequency of urination, polyuria, erectile dysfunction, edema, pedal edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenic purpura, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory loss, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, shortness of breath, rhinitis, vomiting, indigestion, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, micturition disorder, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival polymorphism
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature in a range between 1°C and 30°C to safely preserve the effectiveness of the medication.
Dark yellow round film-coated tablet
28 tablets/box [(14 tablets/Alu-Alu X2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.